Evidence map›Paper›PMID 41109950›Full record

ReviewThe American journal of case reports2025

Escherichia coli-Induced Aortitis and Aortic Perforation: A Case Study and Literature Review.

Hiba Abdelkareem, Saif Aldeen Jabarin, Ahmad Farhoud, Yuval Schwartz, Ilya Goldin, Gabriel Munter

Abstract readCase ReportsReview
In one paragraph

Review in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Clinical case reports · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hiba AbdelkareemDepartment of Internal Medicine C, Shaare Zedek Medical Center, Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.
Saif Aldeen JabarinDepartment of Internal Medicine C, Shaare Zedek Medical Center, Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.
Ahmad FarhoudDepartment of Radiology, Shaare Zedek Medical Center, Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.
Yuval SchwartzDepartment of Internal Medicine C, Shaare Zedek Medical Center, Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.
Ilya GoldinVascular Surgery Unit, Shaare Zedek Medical Center, Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.
Gabriel MunterDepartment of Internal Medicine C, Shaare Zedek Medical Center, Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Inflammation of the aorta is a potentially life-threatening condition. Infectious aortitis has been associated with various pathogens, although Escherichia coli has rarely been implicated. CASE REPORT We describe an 82-year-old man with a past medical history of diabetes mellitus type II and ischemic heart disease, who presented with a 2-week history of back and abdominal pain. Imaging revealed aortitis with a periaortic fluid collection, from which E. coli was isolated. The patient underwent urgent endovascular aneurysm repair (EVAR) and was treated with 4 weeks of intravenous cefuroxime followed by prolonged oral antibiotics, with normalization of inflammatory markers. Four months later he was readmitted because of septic shock and a large periaortic abscess was diagnosed. He required open drainage and aortic repair and died of complications. We review the literature of 33 cases involving E. coli aortitis, including the present case, of whom the mean age was 69±11, 26 (79%) were male, 31 (94%) were diagnosed by computed tomography (CT) scan, and 27/31 (87%) received surgical intervention. Further, 25 out of 30 patients (83%) for whom all data regarding interventions and survival were available, survived. CONCLUSIONS Aortitis due to E.coli is a potentially fatal infection. Treatment consists preferably of a combination of prolonged intravenous antibiotics - for at least 6 to 12 weeks - and a surgical intervention. If possible, the patient should undergo EVAR, and if not, open corrective surgery, which is associated with a survival rate of 83%.

Indexed as

AortitisEscherichia coliEscherichia coli InfectionsAged, 80 and overAnti-Bacterial AgentsFatal OutcomeHumansMaleAnti-Bacterial Agents

Identifiers

PMID41109950
PMCPMC12548485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.